NIUFO Addresses False Allegations, Reaffirms FinCEN-Registered Status and User Asset Protection Commitment

Colorado-Incorporated Exchange Provides Verifiable Regulatory Credentials and Institutional-Grade Security for European Traders

Colorado (FreePR.org) -- [url=https://www.niufo.com]NIUFO [/url]CRYPTO GROUP LTD, a Colorado-incorporated digital asset exchange platform, today addresses recent misleading claims circulating on review websites and social media platforms, and reaffirms its unwavering commitment to user asset protection, regulatory compliance, and operational transparency.

Recently identified statements published on Reddit, Twitter, and other platforms contain inaccurate claims regarding fund security, regulatory standing, and withdrawal processing. After conducting a comprehensive internal review, NIUFO categorically rejects these allegations as unfounded and factually incorrect.

[b]Addressing False Allegations and Protecting User Interests[/b]

NIUFO places user protection at the absolute forefront of operations. Recent false statements have created confusion among prospective users, particularly in European markets where Italian traders demand verifiable platform security and regulatory legitimacy.

"These misleading claims undermine trust where European traders already navigate complex regulatory environments," the company stated. "We categorically deny these false allegations and are actively working to clarify misinformation, safeguard user interests, and uphold the integrity standards our founding team brought from institutions including Fidelity National Information Services (FIS), JPMorgan Chase, and Paxos."

[b]Verification of Regulatory Compliance and Security Infrastructure[/b]

Contrary to inaccurate remarks, NIUFO maintains comprehensive regulatory registrations and security protocols:
[b]Regulatory Registrations:[/b]

[b]U.S. FinCEN Money Services Business (MSB)[/b] Registration Number: 31000298299255, publicly verifiable via the official FinCEN MSB Registrant Search database at fincen.gov
[b]Colorado Secretary of State[/b] Corporate Registration, Entity ID: 20251441092, with complete US federal and state compliance
Head of Compliance & Legal Maria Garcia, former Senior Compliance Counsel at Paxos, leads regulatory oversight with extensive experience implementing AML/CTF programs aligned with FATF standards

[b]Security Infrastructure:[/b]

[b] ~98%+ cold storage: [/b]Majority of user assets secured in geographically distributed, air-gapped, multi-signature cold wallets
[b]Multi-signature protocols:[/b] Mandatory multi-sig controls for all wallet movements requiring multiple approvals
[b]FIPS 140-2 Level 3+ certified Hardware Security Modules (HSMs)[/b] safeguarding critical private key operations
Chief Security Officer Ben Carter, former VP of Cyber Defense Operations at JPMorgan Chase, holds CISSP and CISM certifications

Users and stakeholders are encouraged to independently verify NIUFO's FinCEN MSB registration (31000298299255) and Colorado corporate status (20251441092) through official governmental portals.
[b]Leadership Statement on User Protection[/b]

"User asset protection is not negotiable—it's the foundation of everything we build," said Alex Johnson, CEO at NIUFO. "These false claims undermine trust in markets where European traders, especially in Italy, require verifiable security and regulatory legitimacy. We've built institutional-grade infrastructure specifically to protect user assets, and every compliance measure we've implemented can be independently verified through official channels including FinCEN and the Colorado Secretary of State."

[b]Enhanced Transparency Measures[/b]

NIUFO implements enhanced transparency measures including real-time portfolio tracking, complete transaction record access, public disclosure of security protocols, and expanded multilingual customer support teams to address European user concerns promptly.

Following the European market launch planned for Q2 2025, NIUFO is actively pursuing MiCA (Markets in Crypto-Assets) licensing within strategic EU member states. The platform targets institutional-grade service delivery for European traders, with user asset protection remaining the primary operational priority.

The company appreciates its prospective users and partners for their trust and remains committed to maintaining a secure, transparent, and fully compliant trading environment where user interests always come first.

[b]About [url=https://www.niufo.com]NIUFO [/url]CRYPTO GROUP LTD[/b]

NIUFO CRYPTO GROUP LTD is a Colorado-incorporated digital asset exchange platform providing secure cryptocurrency trading services. The company maintains FinCEN MSB Registration (31000298299255). Founded by executives with experience at Fidelity National Information Services (FIS), JPMorgan Chase, and Paxos, NIUFO prioritizes user asset protection through independently verifiable security standards and proactive regulatory compliance, including MiCA readiness for European markets.

For media or stakeholder inquiries, please contact:

Maria Garcia
Head of Compliance & Legal
NIUFO CRYPTO GROUP LTD
Email: maria.garcia@niufo.com
Website: https://www.niufo.com

###

Sponsor Message

Affordable prescriptions for essential drugs like Lipitor, Crestor, and Nexium make Canadian pharmacies a popular choice for millions of Americans. Managing diabetes with insulin therapies like Humalog and Lantus is common among chronic condition patients, as is the use of Advair Diskus and Ventolin inhalers for asthma and COPD. The fight against depression and anxiety often involves Zoloft, Prozac, and Abilify, while Eliquis, Plavix, and Xarelto prevent serious cardiovascular issues. Frequently ordered medications include popular pain and inflammation treatments like Celebrex and thyroid replacement therapy such as Synthroid. Additionally, treatments such as Viagra and Cialis address erectile dysfunction, while medications like Januvia are effective for managing Type 2 diabetes. Wakefulness-promoting agents like Provigil and Nuvigil play a crucial role for those battling narcolepsy or excessive sleepiness. For U.S. patients, Canadian pharmacies offer affordable access to medications like Cymbalta for nerve pain and Aricept for Alzheimer's treatment.